F. Khan

发表

Assessment of fidelity and utility of the whole-genome amplification for the clinical tests offered in a histocompatibility and immunogenetics laboratory.

F. Khan, A. Liacini, E. Arora, 2012, Tissue antigens.

Influence of Chemotherapy on Allergen-Specific IgE

J. Storek, F. Khan, S. Whiteside, 2018, International Archives of Allergy and Immunology.

Reconstitution of the immune system after hematopoietic stem cell transplantation in humans

J. Passweg, J. Storek, B. Huard, 2008, Seminars in Immunopathology.

Immune cell subset counts associated with graft-versus-host disease.

J. Storek, J. Luider, A. Mansoor, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Comparison of abacavir‐specific effector and proliferating functions of CD8 T cells in abacavir‐treated HIV‐1 patients

J. Gill, Stuti N Patel, F. Khan, 2019, Microbiology and immunology.

A biomarker-guided, prospective, phase 2 trial of pre-emptive graft-versus-host disease therapy using anti-thymocyte globulin.

J. Storek, A. Kalra, F. Khan, 2021, Cytotherapy.

Genomic instability after allogeneic hematopoietic cell transplantation is frequent in oral mucosa, particularly in patients with a history of chronic graft-versus-host disease, and rare in nasal mucosa.

J. Storek, D. Stewart, J. Russell, 2010, Blood.

Efficacy of allogeneic hematopoietic cell transplantation for autoimmune diseases.

G. Hazlewood, J. Storek, P. Beck, 2021, Transplantation and cellular therapy.

Epithelial cells in PBSC grafts: source of donor-type epithelial cells after allogeneic transplantation?

J. Storek, J. Russell, F. Khan, 2012, Bone Marrow Transplantation.

Nasal epithelial cells of donor origin after allogeneic hematopoietic cell transplantation are generated at a faster rate in the first 3 months compared with later posttransplantation.

J. Storek, J. Russell, G. Sinclair, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Is allergic disease curable or transferable with allogeneic hematopoietic cell transplantation?

W. Henderson, T. Hallstrand, J. Storek, 2009, Blood.

Antirelapse effect of pretransplant exposure to rabbit antithymocyte globulin.

D. Mahoney, J. Storek, V. Jimenez-Zepeda, 2019, Blood advances.

High serum level of antithymocyte globulin immediately before graft infusion is associated with a low likelihood of chronic, but not acute, graft-versus-host disease.

C. Griffiths, J. Storek, D. Stewart, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Immune reconstitution after hematopoietic cell transplantation

J. Storek, Mark Bosch, F. Khan, 2012, Current opinion in hematology.

Epstein-barr virus DNAemia monitoring for the management of post-transplant lymphoproliferative disorder.

R. Tellier, J. Storek, V. Jimenez-Zepeda, 2018, Cytotherapy.

CD-34+ and VE-cadherin+ endothelial progenitor cells in preeclampsia and normotensive pregnancies.

K. Yusuf, B. Alshaikh, F. Khan, 2019, Pregnancy hypertension.

Curability and transferability of atopy with allogeneic hematopoietic cell transplantation

S. Spellman, J. Brandwein, R. Leigh, 2020, Bone Marrow Transplantation.

Mild clinical course of SARS-coronavirus-2 infection early posttransplant in patients with adoptively transferred antibody response

J. Kanji, J. Storek, A. Kalra, 2021, Bone Marrow Transplantation.

Incomplete chimerism following myeloablative and anti-thymocyte globulin-conditioned hematopoietic cell transplantation is a risk factor for relapse and chronic graft-versus-host disease.

J. Storek, P. Duggan, V. Jimenez-Zepeda, 2022, Cytotherapy.

Immune reconstitution after anti-thymocyte globulin-conditioned hematopoietic cell transplantation.

D. Maloney, M. Boeckh, J. Storek, 2012, Cytotherapy.

Risk factors for the incidence of PTLD and the mortality due to PTLD after hematopoietic cell transplantation.

J. Storek, P. Duggan, V. Jimenez-Zepeda, 2021, Transplantation and cellular therapy.

High incidence of Pneumocystis jirovecii pneumonia in allogeneic hematopoietic cell transplant recipients in the modern era.

J. Storek, P. Duggan, J. Tay, 2019, Cytotherapy.

Low Counts of B Cells, Natural Killer Cells, Monocytes, Dendritic Cells, Basophils, and Eosinophils are Associated with Postengraftment Infections after Allogeneic Hematopoietic Cell Transplantation.

J. Storek, J. Luider, A. Mansoor, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Rituximab toxicity after preemptive or therapeutic administration for post-transplant lymphoproliferative disorder.

J. Storek, P. Duggan, A. Kalra, 2022, Transplantation and cellular therapy.

Hematopoietic cell transplant outcomes after myeloablative conditioning with fludarabine, busulfan, low‐dose total body irradiation, and rabbit antithymocyte globulin

J. Storek, P. Duggan, V. Jimenez-Zepeda, 2020, Clinical transplantation.

Impact of Donor and Recipient Cytomegalovirus Serostatus on Outcomes of Antithymocyte Globulin-Conditioned Hematopoietic Cell Transplantation.

J. Storek, D. Stewart, A. Kalra, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Basophil activation test compared to skin prick test and fluorescence enzyme immunoassay for aeroallergen-specific Immunoglobulin-E

A. Lyon, J. Storek, Cathy Lu, 2012, Allergy, Asthma & Clinical Immunology.

Graft Inflammation and Histologic Indicators of Kidney Chronic Allograft Failure: Low-Expressing Interleukin-10 Genotypes Cannot Be Ignored

H. Benediktsson, S. Yilmaz, A. Sar, 2010, Transplantation.

IL15 levels on day 7 after hematopoietic cell transplantation predict chronic GVHD

A. Lyon, J. Storek, J. Russell, 2013, Bone Marrow Transplantation.

Antithymocyte Globulin at Clinically Relevant Concentrations Kills Leukemic Blasts.

J. Brandwein, J. Storek, J. Luider, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Antithymocyte Globulin at Clinically Relevant Concentration Kills Leukemic Blasts

J. Brandwein, J. Storek, J. Luider, 2015 .

Donor serostatus has an impact on cytomegalovirus-specific immunity, cytomegaloviral disease incidence, and survival in seropositive hematopoietic cell transplant recipients.

K. Fonseca, F. Zhou, J. Storek, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Donor Genetic Predisposition to High Interleukin-10 Production Appears Protective against Acute Graft-Versus-Host Disease

J. Storek, A. Kalra, G. Tripathi, 2022, International journal of molecular sciences.

Rabbit Antithymocyte Globulin Serum Levels: Factors Impacting the Levels and Clinical Outcomes Impacted by the Levels.

J. Storek, J. Luider, F. Khan, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

More acute lymphoid leukemia than acute myeloid leukemia blasts are killed by rabbit antithymocyte globulin.

J. Storek, F. Khan, M. Modi, 2019, Cytotherapy.

Title Donor-Recipient Matching for KIR Genotypes Reduces Chronic GVHD and Missing Inhibitory KIR Ligands Protect against Relapse after Myeloablative , HLA Matched Hematopoietic Cell Transplantation

J. Storek, R. Rajalingam, G. Tripathi, 2016 .

High incidence of hematologic malignancy relapse after allogeneic transplantation in patients with low Epstein-Barr virus-specific T-cell counts.

R. Tellier, J. Storek, A. Kalra, 2019, Cytotherapy.

Impaired natural killer cell counts and cytolytic activity in patients with severe COVID-19

J. C. Cohen Tervaert, J. Storek, A. Kalra, 2020, Blood Advances.

JAK2-tree: a simple CBC-based decision rule to guide appropriate JAK2 V617F mutation testing

Faisal Khan, Etienne Mahe, Kasper Mønsted Pedersen, 2018, Journal of Clinical Pathology.

Low cytomegalovirus-specific T-cell counts at reactivation are associated with progression to high-level viremia or disease in seropositive recipients of hematopoietic cell grafts from seropositive but not seronegative donors.

K. Fonseca, F. Zhou, J. Storek, 2012, Cytotherapy.

Allergen-specific T cell quantity in blood is higher in allergic compared to nonallergic individuals

J. Storek, J. Luider, Cathy Lu, 2011, Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology.

Allergy transfer with hematopoietic cell transplantation from an unrelated donor

A. Lyon, L. Huebsch, J. Storek, 2011, Bone Marrow Transplantation.

Risk factors for post‐transplant lymphoproliferative disorder after Thymoglobulin‐conditioned hematopoietic cell transplantation

R. Tellier, J. Storek, V. Jimenez-Zepeda, 2018, Clinical transplantation.

Human leukocyte antigen (HLA) and pharmacogenetics: screening for HLA-B*57:01 among human immunodeficiency virus-positive patients from southern Alberta.

J. Gill, F. Khan, A. Liacini, 2012, Human immunology.

EXERCISE in pediatric autologous stem cell transplant patients: a randomized controlled trial protocol

S. Culos-Reed, S. Culos-Reed, R. Reimer, 2012, BMC Cancer.

Relevant SARS-CoV-2 Genome Variation through Six Months of Worldwide Monitoring

Brahim Admou, A. Kaur, Hafid Soualhine, 2021, BioMed research international.

Anti-thymocyte globulin’s activity against acute myeloid leukemia stem cells

J. Brandwein, J. Storek, J. Luider, 2018, Bone Marrow Transplantation.